The Architecture of Macular Neovascularizations Predicts Treatment Responses to Anti-VEGF Therapy in Neovascular AMD.
Henrik FaatzKai RothausMartin ZieglerMarius BookGeorg SpitalClemens LangeAlbrecht LommatzschPublished in: Diagnostics (Basel, Switzerland) (2022)
The size, the total vessel length, and the fractal dimension of MNV at baseline are predictors for the treatment response to anti-VEGF therapy. Therefore, particularly regarding the development of new classes of drugs, these parameters could yield new insights into treatment response.